Follow-The-Filings

Holders · period archive

TAK · Takeda Pharmaceutical Co. Ltd

Q4 2025 13F holders among managers we track latest ownership dossier

Ticker
TAK
Type
Equity
Class
SPONSORED ADS
Total reported value ($000, long equity)
Manager Report date Value Shares